The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
Self-citationVascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Allen, T. M., Hansen, C., Martin, F., Redemann, C., & Yau-Young, A. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90246-5 · Cited by 1,391
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Transport of molecules across tumor vasculature
Jain, R. K. (1987) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00047468 · Cited by 866
The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer
Hawthorne, M. F. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199309501 · Cited by 865
Liposomes for the sustained drug release in vivo
Blume, G., & Cevc, G. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90440-y · Cited by 698
Dvorak, H. F., Nagy, J. A., Dvorák, J., & Dvořàk, A. M. (1988) · PubMed Central · Cited by 679
Pharmacokinetics of stealth versus conventional liposomes: effect of dose
Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573
Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo
Maeda, H., Seymour, L. W., & Miyamoto, Y. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00017a001 · Cited by 560
Liu, D., Mori, A., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90136-a · Cited by 463
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizon, A. A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 458
Allen, C., Dos Santos, N., Gallagher, R., Chiu, G. N. C., Shu, Y., Li, W. M., Johnstone, S. A., Janoff, A. S., Mayer, L. D., Webb, M. S., et al. (2002) · Bioscience Reports · doi:10.1023/a:1020186505848 · Cited by 388
Liposomal encapsulated anti-cancer drugs
Hofheinz, R.-D., Gnad-Vogt, S. U., Beyer, U., & Hochhaus, A. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000167902.53039.5a · Cited by 355
Ishida, O., Maruyama, K., Sasaki, K., & Iwatsuru, M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00256-2 · Cited by 308
Self-citationMicroscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice.
Huang, S. K., Lee, K. D., Hong, K., Friend, D. S., & Papahadjopoulos, D. (1992) · PubMed · Cited by 297
Liposomal Drug Formulations: Rationale for Development and What We Can Expect for the Future
Allen, T. M. (1998) · Drugs · doi:10.2165/00003495-199856050-00001 · Cited by 283
Wagner, E., Curiel, D., & Cotten, M. (1994) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(94)90008-6 · Cited by 275
Pros and Cons of the Liposome Platform in Cancer Drug Targeting
Gabizon, A. A., Shmeeda, H., & Zalipsky, S. (2006) · Journal of Liposome Research · doi:10.1080/08982100600848769 · Cited by 272
Maruyama, K., Takizawa, T., Yuda, T., Kennel, S. J., Huang, L., & Iwatsuru, M. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00263-o · Cited by 265
Self-citationEffective anti-tumor activity of oxaliplatin encapsulated in transferrin–PEG-liposome
Suzuki, R., Takizawa, T., Kuwata, Y., Mutoh, M., Ishiguro, N., Utoguchi, N., Shinohara, A., Eriguchi, M., Yanagie, H., & Maruyama, K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.010 · Cited by 250
Self-citationWaterhouse, D. N., Tardi, P. G., Mayer, L. D., & Bally, M. B. (2001) · Drug Safety · doi:10.2165/00002018-200124120-00004 · Cited by 242
Future directions of liposome- and immunoliposome-based cancer therapeutics
Park, J. W., Benz, C. C., & Martin, F. J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.009 · Cited by 240
Maruyama, K., Yuda, T., Okamoto, A., Kojima, S., Suginaka, A., & Iwatsuru, M. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90255-t · Cited by 230
Self-citationPossibility of active targeting to tumor tissues with liposomes
Maruyama, K., Ishida, O., Takizawa, T., & Moribe, K. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00042-3 · Cited by 211
Self-citationMaruyama, K., Ishida, O., Kasaoka, S., Takizawa, T., Utoguchi, N., Shinohara, A., Chiba, M., Kobayashi, H., Eriguchi, M., & Yanagie, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.018 · Cited by 207
Self-citationTumor targeting using liposomal antineoplastic drugs
Huwyler, J. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1253 · Cited by 182
Maruyama, K., Takahashi, N., Tagawa, T., Nagaike, K., & Iwatsuru, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00905-8 · Cited by 170
Self-citationCardiac safety of liposomal anthracyclines
Ewer, M. S., Martin, F. J., Henderson, I. C., Shapiro, C. L., Benjamin, R. S., & Gabizon, A. A. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.08.006 · Cited by 160
Unezaki, S., Maruyama, K., Hosoda, J.-I., Nagae, I., Koyanagi, Y., Nakata, M., Ishida, O., Iwatsuru, M., & Tsuchiya, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04674-1 · Cited by 158
Self-citationDaemen, T., Hofstede, G., ten Kate, M. T., Bakker‐Woudenberg, I. A. J. M., & Scherphof, G. L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610520 · Cited by 153
Sadzuka, Y., Nakade, A., Hirama, R., Miyagishima, A., Nozawa, Y., Hirota, S., & Sonobe, T. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00075-3 · Cited by 139
Mross, K. B., Niemann, B., Massing, U., Drevs, J., Unger, C., Bhamra, R. K., & Swenson, C. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0825-y · Cited by 137
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): Phase I study
Stathopoulos, G. P., Boulikas, T., Vougiouka, M., Deliconstantinos, G., Rigatos, S., Darli, E., Viliotou, V., & Stathopoulos, J. (2005) · Oncology Reports · doi:10.3892/or.13.4.589 · Cited by 128
The Transferrin Receptor: Its Diagnostic Value and its Potential as Therapeutic Target
Thorstensen, K., & Romslo, I. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519309090703 · Cited by 113
Characterization of In Vivo Immunoliposome Targeting to Pulmonary Endothelium
Maruyama, K., Holmberg, E. G., Kennel, S. J., Klibanov, A. L., Torchilin, V. P., & Huang, L. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600791107 · Cited by 110
Self-citationHamilton, A. L., Biganzoli, L., Coleman, R. E., Mauriac, L., Hennebert, P., Awada, A. H., Nooij, M., Beex, L. V. A. M., Piccart, M. J., Hoorebeeck, I. V., et al. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf157 · Cited by 105
Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo.
Aragnol, D., & Leserman, L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2699 · Cited by 101
Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages
DERKSEN, J. T. P., Morselt, H. W. M., & Scherphof, G. L. (1988) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(88)90184-x · Cited by 97
Phosphatidyl polyglycerols prolong liposome circulation in vivo
Maruyama, K., Okuizumi, S., Ishida, O., YAMAUCHI, H., KIKUCHI, H., & Iwatsuru, M. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90407-3 · Cited by 92
Self-citationA phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin
Sankhala, K. K., Mita, A. C., Adinin, R., Wood, L. M., Beeram, M., Bullock, S., Yamagata, N., Matsuno, K., Fujisawa, T., & Phan, A. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.2535 · Cited by 84
The tumor blood vessel as an ideal target for macromolecular anticancer agents
Maeda, H. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90086-7 · Cited by 81
Unezaki, S., Maruyama, K., Ishida, O., Suginaka, A., Hosoda, J.-I., & Iwatsuru, M. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04074-9 · Cited by 52
Self-citationBrain drug delivery and blood–Brain barrier transport
Pardridge, W. M. (1993) · Drug Delivery · doi:10.3109/10717549309022762 · Cited by 50
Some negatively charged phospholipid derivatives prolong the liposome circulation in vivo
Park, Y. S., Maruyama, K., & Huang, L. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90034-j · Cited by 44
Self-citationTransferrin receptor in oral tumors
Miyamoto, T., Tanaka, N., Eishi, Y., & Amagasa, T. (1994) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0901-5027(05)80039-6 · Cited by 41
The reticuloendothelial system and bloodstream clearance.
Frank, M. M. (1993) · PubMed · Cited by 39
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Walkey, C. D., & Chan, W. C. W. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15233e · Cited by 1,758
Zhou, J., Yu, G., & Huang, F. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00898d · Cited by 677
Eloy, J. O., Claro de Souza, M., Petrilli, R., Barcellos, J. P. A., Lee, R. J., & Marchetti, J. M. (2014) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2014.09.029 · Cited by 529
Kievit, F. M., & Zhang, M. (2011) · Advanced Materials · doi:10.1002/adma.201102313 · Cited by 496
Metadata
- Authors
- Maruyama, K.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 63
- Issue
- 3
- Pages
- 161-169
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2095142763
- Cited by
- 601
- References
- 50
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.